Press "Enter" to skip to content

PharmEasy is closing in on $120m in equity round

The transaction, which is expected to close by the end of the month, will value the five-yearold company at $500-600 million, according to multiple sources aware of the development.

Original source:

Also Read:   Central drug regulator preparing list of dual-use APIs imported from unregistered firms